Delivery Order SPE2DR25D3101-SPE2DR26F6A70
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,231.14 to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors, with an ultimate completion date of October 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a routine pharmaceutical supply transaction under the company's broader federal contract portfolio. The product will be delivered to the contracting office in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $2,273.90 to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors, with an ultimate completion date of December 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the contractor's headquarters location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,004.40 to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 26, 2026, for the supply of Emgality 120 mg/ml pen injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 27, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a task order under a larger Indefinite Delivery Contract vehicle with the...
- The Defense Logistics Agency awarded a delivery order valued at $11,329.50 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pen injectors. This firm fixed-price, competitively awarded delivery order was issued on September 5, 2025, with an ultimate completion date of September 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is...
- The Defense Logistics Agency awarded a $1,729.00 delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors on August 5, 2025, with an ultimate completion date of August 6, 2025. This contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement fulfilling...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,008.80 for Emgality 120 mg/ml pen injectors on November 14, 2025, with completion expected by November 17, 2025. This firm fixed price, non-set-aside contract was awarded competitively and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's broader contracting relationship with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors valued at $3,013.20, with a firm fixed price and ultimate completion date of December 12, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,221.46 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with a completion date of September 5, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $3,309.37 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pen injectors. This firm fixed price, competitively awarded contract was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,725.65 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/mL pen injectors. This contract, awarded on January 5, 2026, with an ultimate completion date of January 6, 2026, represents a competitively awarded, non-set-aside order under a firm fixed price arrangement. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued as a child...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F6A70Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,348.00 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pen injectors, with an ultimate completion date of January 30, 2026. This competitively awarded, non-set-aside contract reflects a firm fixed-price arrangement and represents a single task order under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its critical role as a major pharmaceutical distributor serving military treatment facilities, the Defense Health Agency, and other federal medical institutions across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 1/28/26 |